BioSpace News Archive

Vulnerabilities found in BD Alaris Gateway Workstation affirmed by ICS-CERT with CVSS scores of 10.0 and 7.3 respectively

Health Canada officials will hold a media technical briefing regarding the next steps in the legalization and regulation of cannabis.

On June 12, 2019, Vice Chancellor Joseph Slights of the Court of Chancery of the State of Delaware issued an oral ruling granting the motion of Macrophage Therapeutics, Inc. (“MT”), a subsidiary of Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), to declare as void certain transactions putatively authorized by MT’s former Chief Executive Officer

First-of-its-kind resource decodes the tax-advantaged tool about to stir up group insurance market

Avalon GloboCare Corp. announced the Company’s President and Chief Executive Officer, David Jin. M.D., Ph.D., will participate at the Second International Aesthetic Industry Conference in Chengdu, China, the largest scale of its kind across all of Asia.

The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products

Topline results expected by end of 2019

UK-headquartered EMMAC is a European medical cannabis company, combining the latest science and research with cutting-edge cultivation, extraction, and production.

Acquisition strengthens integrated drug development solution and expands global footprint

JMP Securities Life Sciences Conference on Wednesday, June 19, 2019, at 1:30 PM EDT. The conference will take place June 19-20, 2019, in New York City.